HCPCS code Q4154 – Biovance amniotic membrane allograft billing

Key Takeaways

HCPCS code Q4154 describes Biovance, an amniotic membrane allograft, billed per square centimeter of surface area applied

Medicare reimburses Q4154 at approximately $127 per cm2; units must equal the exact wound surface area covered

Many Medicare Advantage and Medicaid managed care plans require prior authorization before application

Pabau’s claims management software tracks wound measurements, links ICD-10 codes, and flags PA requirements before submission

HCPCS code Q4154: definition and code details

HCPCS code Q4154 is a Level II code maintained by the Centers for Medicare and Medicaid Services (CMS) that describes Biovance, an amniotic membrane allograft, per square centimeter. It sits within the Q4100-Q4299 series reserved for skin substitute products under Medicare’s fee-for-service and managed care programmes.

Biovance is manufactured by Celularity (formerly Amniox Medical). It is a dehydrated, decellularized amniotic membrane derived from human placental tissue. Because it is a tissue product rather than a drug or durable medical equipment item, it is coded with a HCPCS Q-code rather than a CPT or J-code.

What Q4154 covers and what it excludes

Q4154 covers the supply of Biovance amniotic membrane allograft when applied to an appropriate wound. Coverage is contingent on the wound type, the clinical setting, and the payer’s local coverage determination (LCD).

Covered wound types

• Diabetic foot ulcers (DFU) and lower extremity diabetic wounds
• Venous leg ulcers
• Pressure injuries (stage 3 and 4)
• Chronic wounds that have failed conventional treatment for four or more weeks
• Post-surgical wounds with delayed healing

What Q4154 does not cover

• Acute traumatic wounds not requiring advanced wound care
• Burns covered by other HCPCS codes
• Applications of a different amniotic or skin substitute product (each has its own Q-code)
• The application procedure itself – that is billed separately using CPT codes 15271-15278

A common billing error is using Q4154 when a different amniotic product was actually applied. The code is product-specific; if a clinician switches from Biovance to EpiFix mid-treatment, the code changes to Q4186 or Q4187, not Q4154.

How to calculate and bill units for Q4154

Units for Q4154 equal the total surface area of Biovance applied, measured in square centimeters. Measure the wound at its widest length and widest width, then multiply: length (cm) x width (cm) = units to bill.

Bill only the area actually covered by the product, not the full wound area if the graft did not cover the entire surface. Accurate wound measurement is both a billing requirement and a medical record necessity.

Rates are approximate based on the ~$127/cm2 Medicare reference rate. Always verify the current rate using the CMS Physician Fee Schedule lookup tool, as rates update annually on January 1.

Q4154 is always billed alongside a companion CPT application code from the 15271-15278 series. The CPT code captures the work of applying the graft; Q4154 captures the product cost. Both must appear on the same claim.

ICD-10 diagnosis codes used with Q4154

The diagnosis code on a Q4154 claim must match the wound type being treated and must satisfy the payer’s LCD criteria for skin substitute coverage. Mismatched or insufficiently specific ICD-10 codes are among the top three denial triggers for this code.

Use the most specific code available. “Unspecified” ulcer codes frequently trigger automated denials under MAC LCDs because they do not confirm the clinical criteria for skin substitute coverage. When a diabetic foot ulcer is the primary diagnosis, code E11.621 first, then the L97 series to specify the anatomical site and depth.

Medicare reimbursement rate for Q4154 billing

Medicare reimburses Q4154 at approximately $127 per square centimeter under the Medicare Physician Fee Schedule (MPFS). This rate applies to non-facility settings such as outpatient wound care clinics. Facility settings (hospital outpatient departments) may have different rates under the Outpatient Prospective Payment System (OPPS).

Payment is calculated by multiplying the number of units billed by the per-unit rate. For a 24-unit claim (4 cm x 6 cm wound), the Medicare payment would be approximately $3,048 before geographic adjustment. Geographic practice cost indices (GPCIs) can shift the final payment by a few percent in either direction depending on the practice location.

Pabau’s claims management software links wound measurements directly to HCPCS unit calculations, reducing arithmetic errors that lead to overpayment recovery audits. Track each application session separately when Biovance is applied across multiple visits.

Prior authorization requirements for Q4154

Traditional Medicare (Parts A and B) does not require prior authorization for Q4154, but most Medicare Advantage plans and Medicaid managed care plans do. Submitting a Q4154 claim without a required PA is the single most common reason for denial on this code.

Check insurance eligibility verification before each application session, not just at the start of a treatment course. PA approvals can lapse mid-treatment if the wound has not responded as expected or if the payer’s policy requires re-authorization after a set number of applications.

PA documentation typically requires: confirmed diagnosis with wound type and chronicity, wound measurement records, photos taken at least four weeks apart, documentation of failed conventional wound care, and the product lot number or purchase order. Requirements vary by plan year, so verify directly with the payer before each application course.

Q4154 vs similar skin substitute codes: avoiding mix-ups

Q4154 is one of over 100 HCPCS Q-codes for skin substitute products. Each code is product-specific. Billing the wrong code – even for a clinically equivalent product – constitutes incorrect coding and can trigger a refund demand or compliance audit.

Never substitute Q4100 (the “not otherwise specified” catch-all) for Q4154. Payers who cover Biovance by name will deny a Q4100 claim for the same product on the grounds that a specific code exists. The reverse is also true: Q4100 is the correct code only when no product-specific code has been assigned by CMS.

Use the AAPC HCPCS code lookup or the PGM Billing HCPCS tool to confirm the current code assignment before each product’s first claim in a plan year.

Q4154 documentation requirements

Strong documentation is the foundation of every successful Q4154 claim. Medicare Administrative Contractors (MACs) and managed care plans frequently audit skin substitute claims because of their high per-unit cost. Missing a single required element is enough to trigger a full recoupment demand.

The medical record must contain all of the following before a claim is submitted. Good medical billing compliance practice means building this checklist into the clinical workflow, not the billing workflow.

• Wound measurement log: recorded at each encounter, with length x width (and depth where relevant), in centimeters
• Wound photographs: date-stamped, showing wound dimensions and healing progress across visits
• Diagnosis confirmation: ICD-10 code supported by the clinical note (e.g., confirmed diabetic foot ulcer with wound depth and chronicity documented)
• Treatment failure history: documentation of four or more weeks of conventional wound care (moist dressings, offloading, compression) before skin substitute application
• Product lot or batch number: required for traceability; include on the claim or in the supporting record
• Quantity applied: total surface area covered, matching the units billed on the claim
• Prescribing or ordering clinician: must be enrolled in Medicare and have ordering authority

Common denial reasons for Q4154 claims

Q4154 claims have a higher-than-average denial rate compared with standard wound care codes because every element of the claim – diagnosis, units, documentation, PA – must align precisely. The table below shows the most common denial triggers and the prevention step for each.

A structured approach to denial management in healthcare means tracking Q4154 denials by reason code, not just by volume. A practice that sees repeated CO-197 denials (prior authorization missing) has a workflow problem at the point of scheduling. One that sees repeated CO-4 denials (modifier issue) has a coding problem at claim creation.

Medicaid and commercial payer coverage for Q4154

Medicaid coverage for Q4154 is highly variable. Some state fee-for-service Medicaid programmes cover amniotic membrane allografts under their skin substitute policy; others exclude them entirely or limit coverage to a narrow list of approved products. Always verify with the state Medicaid agency or the managed care plan before treatment.

Commercial payers follow their own medical policies. Most large carriers (Aetna, Cigna, UnitedHealthcare commercial) have specific skin substitute policies that list covered products, required diagnoses, and maximum application frequency. Biovance’s coverage status under commercial plans varies by market and plan year.

Reduce billing errors on high-cost wound care claims

Pabau helps wound care practices track wound measurements, link ICD-10 codes to encounters, manage PA workflows, and submit clean HCPCS claims – all from one system. See how it works for your practice.

Book a demo

Conclusion

Q4154 claims combine a high unit cost with strict documentation, product-specific coding, and variable payer PA rules. The practices that bill Biovance consistently without denials are the ones that treat wound measurement and documentation as clinical tasks, not afterthoughts at billing time.

Pabau’s clean claim workflows let wound care practices link wound measurements to HCPCS unit calculations, attach supporting documentation to each encounter, and track PA status before the claim leaves the practice. To see how it applies to your billing workflow, book a demo.

Continue your research

Want to reduce claim denials across your practice? Denial management in healthcare covers the root causes behind denied claims and how to build a prevention-first billing workflow.

Need a primer on how clearinghouses process wound care claims? Medical claims clearinghouse explains how electronic claims are validated and routed to payers.

Looking for a billing compliance framework? What is medical billing breaks down the end-to-end revenue cycle process for wound care and specialty practices.

Frequently Asked Questions